Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:40:40 GMT 2023
by
admin
on
Sat Dec 16 11:40:40 GMT 2023
|
Protein Type | RECEPTOR |
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
79AAW649HW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
79AAW649HW
Created by
admin on Sat Dec 16 11:40:41 GMT 2023 , Edited by admin on Sat Dec 16 11:40:41 GMT 2023
|
PRIMARY | |||
|
P21452
Created by
admin on Sat Dec 16 11:40:41 GMT 2023 , Edited by admin on Sat Dec 16 11:40:41 GMT 2023
|
PRIMARY | |||
|
P21452
Created by
admin on Sat Dec 16 11:40:41 GMT 2023 , Edited by admin on Sat Dec 16 11:40:41 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_106 | 1_181 |
Glycosylation Type | HUMAN |
Glycosylation Link Type | Site |
---|---|
N | 1_11 |
N | 1_19 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR->OFF-TARGET |
Neratinib concentration at 10 microM
INHIBITOR
Percent inhibition of specific binding
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Tachykinin NK2 receptor antagonist that was developed by Sanofi-Aventis for anti-depressant potential
IC50
|
||
|
INHIBITOR -> TARGET |
Radioligand binding assay
BINDING
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
Ki
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT | CHEMICAL |
|